JP2019123675A5 - - Google Patents

Download PDF

Info

Publication number
JP2019123675A5
JP2019123675A5 JP2018003564A JP2018003564A JP2019123675A5 JP 2019123675 A5 JP2019123675 A5 JP 2019123675A5 JP 2018003564 A JP2018003564 A JP 2018003564A JP 2018003564 A JP2018003564 A JP 2018003564A JP 2019123675 A5 JP2019123675 A5 JP 2019123675A5
Authority
JP
Japan
Prior art keywords
salt
radionuclide
labeled compound
formula
imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018003564A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019123675A (ja
JP6831802B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from JP2018003564A external-priority patent/JP6831802B2/ja
Priority to JP2018003564A priority Critical patent/JP6831802B2/ja
Priority to PCT/IB2019/000060 priority patent/WO2019138296A2/ja
Priority to CN201980007415.2A priority patent/CN111556868B/zh
Priority to KR1020207023105A priority patent/KR102428569B1/ko
Priority to TW108101192A priority patent/TWI818946B/zh
Publication of JP2019123675A publication Critical patent/JP2019123675A/ja
Publication of JP2019123675A5 publication Critical patent/JP2019123675A5/ja
Publication of JP6831802B2 publication Critical patent/JP6831802B2/ja
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018003564A 2018-01-12 2018-01-12 放射性核種標識化合物及びこれを含有するイメージング剤 Active JP6831802B2 (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2018003564A JP6831802B2 (ja) 2018-01-12 2018-01-12 放射性核種標識化合物及びこれを含有するイメージング剤
TW108101192A TWI818946B (zh) 2018-01-12 2019-01-11 放射性核種標識化合物及含有其之成像劑
CN201980007415.2A CN111556868B (zh) 2018-01-12 2019-01-11 放射性核素标记化合物和含有该化合物的显影剂
KR1020207023105A KR102428569B1 (ko) 2018-01-12 2019-01-11 방사성 핵종 표지 화합물 및 이것을 함유하는 이미징제
PCT/IB2019/000060 WO2019138296A2 (ja) 2018-01-12 2019-01-11 放射性核種標識化合物及びこれを含有するイメージング剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018003564A JP6831802B2 (ja) 2018-01-12 2018-01-12 放射性核種標識化合物及びこれを含有するイメージング剤

Publications (3)

Publication Number Publication Date
JP2019123675A JP2019123675A (ja) 2019-07-25
JP2019123675A5 true JP2019123675A5 (https=) 2020-09-17
JP6831802B2 JP6831802B2 (ja) 2021-02-17

Family

ID=67218458

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018003564A Active JP6831802B2 (ja) 2018-01-12 2018-01-12 放射性核種標識化合物及びこれを含有するイメージング剤

Country Status (5)

Country Link
JP (1) JP6831802B2 (https=)
KR (1) KR102428569B1 (https=)
CN (1) CN111556868B (https=)
TW (1) TWI818946B (https=)
WO (1) WO2019138296A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115989029B (zh) * 2020-08-25 2025-07-22 国立研究开发法人量子科学技术研究开发机构 化合物、α突触核蛋白凝集体结合剂及其利用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002085903A2 (en) * 2001-04-23 2002-10-31 The Trustees Of The University Of Pennsylvania Amyloid plaque aggregation inhibitors and diagnostic imaging agents
AU2003304416A1 (en) * 2003-08-13 2005-03-07 Bf Research Institute, Inc. Probe for disease with amyloid deposit, amyloid-staining agent, remedy and preventive for disease with amyloid deposit and diagnostic probe and staining agent for neurofibril change
EP1655287A1 (en) * 2003-08-13 2006-05-10 BF Research Institute, Inc. Probe for diseases with amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change
EP1956013B1 (en) * 2005-11-30 2016-04-13 Fujifilm RI Pharma Co., Ltd. Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
CN101466711A (zh) * 2006-05-19 2009-06-24 日本医事物理股份有限公司 对淀粉状蛋白具有亲和性的新化合物
WO2008078424A1 (ja) * 2006-12-25 2008-07-03 Tohoku University ベンゾキサゾール誘導体
JP4738443B2 (ja) * 2007-05-30 2011-08-03 富士フイルムRiファーマ株式会社 アミロイドの凝集及び/又は沈着に起因する疾患のイメージング薬及び治療薬
CA2725940A1 (en) * 2008-05-30 2009-12-23 Merck Sharp & Dohme Corp. Novel substituted azabenzoxazoles
CA2836872A1 (en) * 2011-05-20 2012-11-29 Nihon Medi-Physics Co., Ltd. Novel compound having affinity for amyloid
JP5167436B2 (ja) * 2011-06-24 2013-03-21 日本メジフィジックス株式会社 新規アミロイド親和性化合物
EP2767532B1 (en) * 2012-12-21 2016-07-13 National Institutes for Quantum and Radiological Science and Technology Novel compound for imaging tau protein accumulated in the brain
CN105229009B (zh) * 2013-05-23 2017-09-29 豪夫迈·罗氏有限公司 作为成像剂的2‑苯基咪唑并[1,2‑a]嘧啶

Similar Documents

Publication Publication Date Title
JP2015517572A5 (https=)
JP2012514007A5 (https=)
JP2011529919A5 (https=)
JP2019516739A5 (https=)
US20100055036A1 (en) Pet visualization of amyloid-associated neuroinflammation in the brain
JP2017515856A5 (https=)
JP2020507589A5 (https=)
HRP20202032T1 (hr) Probe za snimanje huntingtonovog proteina
JP2015508068A5 (https=)
RU2008147002A (ru) Новые соединения, обладающие сродством к амилоиду
JP2019529514A5 (https=)
EA202091766A1 (ru) Композиции для диагностики для пэт-визуализации, способ получения композиции для диагностики и ее применение в диагностике
JP2020519687A5 (https=)
JP2012504581A5 (https=)
JP2019123675A5 (https=)
EA202091767A1 (ru) Новый способ получения визуализирующего соединения
JP2019507155A5 (https=)
JP2018502150A5 (https=)
RU2011111787A (ru) Производные индола, подходящие для визуализации нейровоспаления
JP2009538894A5 (https=)
SV2009003205A (es) Derivados de silicio para obtencion de imagenes por tomografia de emision de positrones (pet)
JP2010502585A5 (https=)
JP2021091670A5 (https=)
RU2014125849A (ru) Контрастное вещество для визуализации перфузии миокарда
JP2016530337A5 (https=)